Morphometric changes in the episodic memory network and tau pathologic features correlate with memory performance in patients with mild cognitive impairment.
about
One-year brain atrophy evident in healthy agingHigh consistency of regional cortical thinning in aging across multiple samples.Development and assessment of a composite score for memory in the Alzheimer's Disease Neuroimaging Initiative (ADNI)Voxel-based morphometry in Alzheimer's disease.Combining MR imaging, positron-emission tomography, and CSF biomarkers in the diagnosis and prognosis of Alzheimer disease.Increased sensitivity to effects of normal aging and Alzheimer's disease on cortical thickness by adjustment for local variability in gray/white contrast: a multi-sample MRI studyCSF biomarkers in prediction of cerebral and clinical change in mild cognitive impairment and Alzheimer's disease.New tools for the study of Alzheimer's disease: what are biomarkers and morphometric markers teaching us?Relations between brain tissue loss, CSF biomarkers, and the ApoE genetic profile: a longitudinal MRI study.Relationship between CSF biomarkers of Alzheimer's disease and rates of regional cortical thinning in ADNI data.Decreased white matter integrity in neuropsychologically defined mild cognitive impairment is independent of cortical thinning.Impact of apolipoprotein E4-cerebrospinal fluid β-amyloid interaction on hippocampal volume loss over 1 year in mild cognitive impairment.Cortical signatures of cognition and their relationship to Alzheimer's disease.CSF biomarker associations with change in hippocampal volume and precuneus thickness: implications for the Alzheimer's pathological cascade.Cognitive Correlates of Basal Forebrain Atrophy and Associated Cortical Hypometabolism in Mild Cognitive ImpairmentMRI of hippocampal volume loss in early Alzheimer's disease in relation to ApoE genotype and biomarkers.Minute effects of sex on the aging brain: a multisample magnetic resonance imaging study of healthy aging and Alzheimer's disease.Allocentric Spatial Memory Testing Predicts Conversion from Mild Cognitive Impairment to Dementia: An Initial Proof-of-Concept Study.White matter integrity and cognition in Parkinson's disease: a cross-sectional study.The concept of FDG-PET endophenotype in Alzheimer's disease.Neuroimaging results impose new views on Alzheimer's disease--the role of amyloid revised.Correlates of Subjective and Mild Cognitive Impairment: Depressive Symptoms and CSF Biomarkers.The Effects of Bushen Capsule on Episodic Memory in Amnestic Mild Cognitive Impairment Patients: A Pilot Placebo Controlled fMRI Study.White matter diffusivity predicts memory in patients with subjective and mild cognitive impairment and normal CSF total tau levels.Pre-dementia memory impairment is associated with white matter tract affection.
P2860
Q24642943-F89CDB13-50F8-44FD-9E80-BC065FD484E5Q30489836-E3702E29-A020-4867-8E08-EA9489BAD0F4Q30552776-D9491DC6-7F3B-4B8A-BE84-FE37B454F86BQ33382837-63773EC6-0FB9-4442-BF60-B6F6C69C6D19Q33651118-ADEA92ED-4DCB-4827-BEE3-E96D97C42E62Q33688690-DC7670FA-D4F1-4E28-A9D6-8B5BC234CB77Q33689474-707974C1-E97F-4519-BDD8-DD86D919BDCEQ33881726-8D92D4E5-557F-4D32-858B-93A3B9D7DC1AQ33987747-7F28FF7D-DF2E-4A4B-9710-E2E0BCEBE254Q34039952-C37FC864-C1E4-45E9-8ABB-03241E14A5F7Q35167339-5CE1CFB9-5AF2-46B1-A2FA-19A51159D6BAQ35224265-DDB35981-C58C-40CD-AB4D-28F3DE6B5ED8Q36558019-C466A0AC-43E6-469E-8790-903360E4B44FQ36851017-62262B7A-B048-4E97-ABAB-43A50869C2C1Q36908486-33C3F275-B30C-40AD-9B24-1F2BDC1B46B8Q37158181-20FC3877-39B9-4D06-8C1C-750782F8A919Q37436262-C7A4C1E5-91F4-4DC6-A0DB-3D110773B1FEQ37459258-E5A2F1A2-6521-4CB5-97F6-F5CC9DB40779Q37517241-24035E1E-73E3-402D-930E-06AA374D2410Q37883153-A0639A4A-5932-49D2-92A8-878DD1BEC905Q37971458-1C72F1AF-6D18-401E-AEC9-19C1153271D3Q42277971-8A015C45-B23D-40C1-B1D2-A471CB5915DFQ48239602-D3176824-4FE1-4F69-BB24-72535D4AD3CBQ48431936-1ABA6DBB-1EEA-41B2-9C93-9881DFEC204BQ51030026-8BAF2515-2632-448E-9B92-4FD848EE3C03
P2860
Morphometric changes in the episodic memory network and tau pathologic features correlate with memory performance in patients with mild cognitive impairment.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh-hant
name
Morphometric changes in the ep ...... ith mild cognitive impairment.
@en
Morphometric changes in the ep ...... ith mild cognitive impairment.
@nl
type
label
Morphometric changes in the ep ...... ith mild cognitive impairment.
@en
Morphometric changes in the ep ...... ith mild cognitive impairment.
@nl
prefLabel
Morphometric changes in the ep ...... ith mild cognitive impairment.
@en
Morphometric changes in the ep ...... ith mild cognitive impairment.
@nl
P2093
P2860
P50
P356
P1476
Morphometric changes in the ep ...... ith mild cognitive impairment.
@en
P2093
A Bjørnerud
A Skinningsrud
P Due-Tønnessen
R Grambaite
T Cappelen
P2860
P304
P356
10.3174/AJNR.A1059
P577
2008-06-01T00:00:00Z